RK Stone Miami

RK Stone is a clinical research center and medical practice based in Miami, Florida, specializing in the execution of Phase I through Phase IV clinical trials. Founded in 1994, the organization has established itself as a premier site for pharmaceutical and biotechnology companies, particularly in the fields of dermatology, internal medicine, and infectious diseases. In addition to its clinical trial services, the entity acts as a strategic investor in the life sciences industry through RK Stone Miami LLC, which is currently the largest shareholder of Scinai Immunotherapeutics (Nasdaq: SCNI). RK Stone is known for its robust patient recruitment, high-quality data collection, and experienced medical staff led by Dr. Richard K. Stone. The company plays a significant role in the South Florida clinical research ecosystem, supporting the development of novel biologics and small molecule therapies.